List of SBIR/STTR awards granted to OASIS PHARMACEUTICALS, LLC
Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A STTR Phase I contract was awarded to OASIS PHARMACEUTICALS, LLC in May, 2018 for $225,769.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R42HL140701-01A1 | Phase I | 225,769 | May 15, 2018 | |||||||
A STTR Phase I contract was awarded to OASIS PHARMACEUTICALS, LLC in September, 2022 for $392,485.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41CA272065-01A1 | Phase I | 392,485 | September 1, 2022 | |||||||
A STTR Phase I contract was awarded to OASIS PHARMACEUTICALS, LLC in September, 2021 for $361,774.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41HL160429-01 | Phase I | 361,774 | September 1, 2021 | |||||||
A STTR Phase II contract was awarded to OASIS PHARMACEUTICALS, LLC in April, 2019 for $750,502.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 4R42HL140701-02 | Phase II | 750,502 | April 1, 2019 | |||||||
A SBIR Phase II contract was awarded to OASIS PHARMACEUTICALS, LLC in September, 2017 for $3,165,348.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44DK101240-04A1 | Phase II | 3,165,348 | September 20, 2017 | |||||||
A STTR Phase I contract was awarded to OASIS PHARMACEUTICALS, LLC in May, 2017 for $366,484.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41HL134517-01A1 | Phase I | 366,484 | May 1, 2017 | |||||||
A STTR Phase II contract was awarded to OASIS PHARMACEUTICALS, LLC in September, 2016 for $1,500,000.0 USD from the U.S. Department of Health & Human Services. | STTR | 4R42AR067617-02 | Phase II | 1,500,000 | September 1, 2016 | |||||||
A STTR Phase II contract was awarded to OASIS PHARMACEUTICALS, LLC in May, 2014 for $1,742,618.0 USD from the U.S. Department of Health & Human Services. | STTR | 4R42DK101240-02 | Phase II | 1,742,618 | May 20, 2014 | |||||||
A STTR Phase I contract was awarded to OASIS PHARMACEUTICALS, LLC in September, 2015 for $225,000.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R42AR067617-01A1 | Phase I | 225,000 | September 1, 2015 | |||||||
A STTR Phase I contract was awarded to OASIS PHARMACEUTICALS, LLC for $304,237.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R42DK101240-01 | Phase I | 304,237 | ||||||||
A STTR Phase II contract was awarded to OASIS PHARMACEUTICALS, LLC in February, 2023 for $999,799.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 2R42HL160429-02 | Phase II | 999,799 | February 1, 2023 |
